| 1 |
Antibody array profiling reveals serum TSP-I as a marker to distinguish benign from malignant prostatic disease |
|
| | Shafer MW, Mangold L, Partin AW, et al. | | | PROSTATE. 2007; 67 (3): 255-267 | | | [Pubmed] [Google Scholar] | | | 2 |
Optimized normalization for antibody microarrays and application to serum-protein profiling |
|
| | Hamelinck D, Zhou HP, Li L, Verweij C, Dillon D, Feng ZD, Costa J, Haab BB | | | MOLECULAR & CELLULAR PROTEOMICS. 2005; 4 (6): 773-784 | | | [Pubmed] [Google Scholar] | | | 3 |
Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers |
|
| | Miller, J.C., Zhou, H., Kwekel, J., Cavallo, R., Burke, J., Butler, E.B., Teh, B.S., Haab, B.B. | | | Proteomics. 2003; 3(1): 56-63 | | | [Pubmed] [Google Scholar] | | | 4 |
Urinary markers for prostate cancer |
|
| | Abdul M, Banks M, Hoosein N | | | INTERNATIONAL JOURNAL OF ONCOLOGY. 1996; 8 (4): 735-739 | | | [Pubmed] [Google Scholar] | | | 5 |
GAMMOPATHY ASSOCIATED WITH ADVANCED PROSTATE CARCINOMA |
|
| | ABDUL M, HOOSEIN NM | | | UROLOGICAL RESEARCH. 1995; 23 (3): 185-188 | | | [Pubmed] [Google Scholar] | |
|
